NEW: Redenlab commence work with Royal Melbourne Hospital on mobile speech recording in multiple sclerosis

In collaboration with the Movement Disorders and Cognitive monitoring in MS group. Speech is being used as an outcome measure in a treatment trial for Tremor in MS.

Tags: , , ,

Related Post

Redenlab study featured in the Huberman Lab Podcast

  • Posted on 27 April, 2023
    Redenlab have been featured in the Huberman Lab Podcast for their study on “Adults with a history of recreational cannabis...
    Read more

    The L16HTHOUSE Study

    • Posted on 30 March, 2023
      L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
      Read more

      Temporary Assessment of Language in Kabuki Syndrome (TALK) Study

      • Posted on 30 March, 2023
        Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate communication. These...
        Read more